Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2017-08-03 Declaration of Voting R…
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in major shareholdings ('Notification of Major Holdings') by BlackRock, Inc. in Fresenius SE & Co. KGaA, referencing German Securities Trading Act (WpHG) sections. This directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which aligns best with the 'Major Shareholding Notification' category (MRQ). Although it is a regulatory announcement, MRQ is more specific than the general RNS fallback.
2017-08-03 English
Half-yearly financial report 2017
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Financial Report' for the Fresenius Group covering the first half and second quarter of 2017. It contains comprehensive financial statements (income, cash flow, balance sheet), segment reporting, and management analysis. It is not an announcement of a report (RPA) or a short summary, but the full interim report itself, fitting the definition of an Interim / Quarterly Report (IR). H2 2017
2017-08-03 German
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'DGAP-DD: Fresenius SE & Co. KGaA english' and contains the header 'Directors’ Dealings'. The content details a transaction ('Grant of stock options under LTIP') by a 'Member of the managing body' (Dr. Francesco De Meo). This directly corresponds to the definition of Director's Dealing, which is classified under the code DIRS.
2017-08-02 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of an individual (Dr. Jürgen Götz), their position ('Member of the managing body'), and the nature of the transaction (Grant of stock options under LTIP). This content directly matches the definition for Director's Dealing.
2017-08-02 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains sections detailing 'Details of the person discharging managerial responsibilities' (a Member of the managing body) and 'Details of the transaction(s)' involving the grant of stock options. This content directly corresponds to the definition of Director's Dealing reports, which track personal share transactions by executives. The appropriate code is DIRS.
2017-08-02 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'DGAP-DD: Fresenius SE & Co. KGaA english' and contains the header 'Directors’ Dealings'. Section 1 identifies the individual as a person discharging managerial responsibilities (Member of the managing body). Section 4 details the transaction involving the 'Grant of stock options under LTIP'. This content directly corresponds to the definition of Director's Dealing reports, which track personal share transactions by executives.
2017-08-02 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.